d at Fort Meade, Maryland. It gives an overview of what in 1998 was state-of-the-art technology for crowd control and other applications. As stated in the article, "The DOD confirmed to New Scientist that it released the documents, which detail five different 'maturing non-lethal technologies' using microwaves, lasers and sound." Over a decade later, not only has this technology advanced, but so has its potential to inflict serious injury and death.
Furthermore, research from Project Censored, substantiates that, "New technological capabilities have been developed in black budget projects over the last few decades-- including the ability to influence human emotion, disrupt thought, and present excruciating pain through the manipulation of magnetic fields. The US military and intelligence agencies have at their disposal frightful new weapons, that have likely already been covertly used and/or tested on humans, both here and abroad, and which could be directed against the public in the event of mass protests or civil disturbance." FFCHS and Attorney Wilson assert that a growing number of Americans are reporting symptoms that include, but are not limited to, severe physical trauma such as shocks, stings, burning, nausea, and sleep deprivation.
Targeted Individuals (TI's) of domestic terrorism originate from many different backgrounds and are affected physically, psychologically, socially, and economically as a result of the organized stalking and DEW torture. FFCHS President, Derrick Robinson explains, "The average American would be astonished to learn the extent to which secret surveillance technology has advanced today; to learn that remote manipulation and torture of the human mind and body is now possible and that all are at risk ofPage: 1 2 3 4 Related biology technology :1
. Supportive devices or unnecessary surveillance?2
. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition3
. U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership4
. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society5
. 17th Annual Congress on Womens Health To Be Held March 27-29, 2009 in Collaboration with American Medical Womens Association (AMWA)6
. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences7
. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer8
. American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering9
. American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock10
. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update11
. CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions